Moderna signs deal with Shanghai to make mRNA vaccines for Chinese market
The Massachusetts-based company will work with local government to conduct clinical trials and apply to bring products to market as well as to produce them in China.
COVAX vaccine initiative has $2.6 billion left to spend as pandemic recedes
The initiative is set to wind up at the end of this year, although some of its work will continue.
Eradicate breast cancer? The hunt for a vaccine looks promising
Women in the future may soon be able to get a series of shots that teach their immune systems how to quash breast cancer before it becomes a problem.
Japan to roll out COVID-19 booster targeting XBB subvariant in the fall
A vaccine subcommittee under the health ministry is aiming to prepare for another spike in infections possibly arriving in the winter.
Cancer vaccines poised to unlock 'new treatment paradigm' with Merck-Moderna data
Scientists have been chasing the dream of vaccines to treat cancer for decades with few successes.
Small measles outbreak in Japan raises alarm
The most recent infections appear to have happened to strangers riding the same shinkansen for less than three hours.
Scientists urge G7 leaders to improve vaccine access in developing countries
Advocates used the summit to push back against the pharmaceutical industry’s pressure to strengthen intellectual property rights.
Japan has a new vaccine research funding unit for future pandemics — is it up to the task?
The country lacked a sense of urgency to prepare for potential outbreaks — this lack of preparedness has had a lasting impact.
G7 leaders' summit statement to target China's 'economic coercion'
G7 leaders are set to discuss concern about China's use of "economic coercion" in its dealings abroad as part of their larger joint statement, a U.S. official said.
Cancer vaccine hunt makes progress, finally
A small cancer drug study shows promise in deploying mRNA technology against melanoma, but fighting tumors is vastly more complex than tackling COVID-19.
Moderna-Merck cancer vaccine plus Keytruda delays recurrence of skin cancer
The findings of the recent trial suggest that adding a personalized cancer vaccine to antibody-based immunotherapy could prolong the time patients have without death or the cancer's return.
Another COVID-like pandemic could hit the world within 10 years
There’s a 27.5% chance a pandemic as deadly as COVID-19 could take place in the next decade, with rapid vaccine rollout key to reducing fatalities, a predictive health analytics firm found.
